209 related articles for article (PubMed ID: 20516160)
1. Antipsychotic dosing: still a work in progress.
Remington G
Am J Psychiatry; 2010 Jun; 167(6):623-5. PubMed ID: 20516160
[No Abstract] [Full Text] [Related]
2. Datapoints: The ups and downs of dosing second-generation antipsychotics.
Citrome L; Jaffe A; Levine J
Psychiatr Serv; 2007 Jan; 58(1):11. PubMed ID: 17215406
[No Abstract] [Full Text] [Related]
3. Switching antipsychotic medications: not enough, too often, or just right?
Weiden PJ
Am J Psychiatry; 2011 Sep; 168(9):882-4. PubMed ID: 21890800
[No Abstract] [Full Text] [Related]
4. Pharmacology of antipsychotics in the elderly: a focus on atypicals.
Finkel S
J Am Geriatr Soc; 2004 Dec; 52(12 Suppl):S258-65. PubMed ID: 15541166
[No Abstract] [Full Text] [Related]
5. Comparing the effectiveness of aripiprazole and quetiapine in schizophrenia and related psychoses: a naturalistic, retrospective chart review study.
Shajahan P; Keith S; Majjiga C; Murphy J; MacRae A; Bashir M; Taylor M
J Clin Psychiatry; 2009 May; 70(5):692-8. PubMed ID: 19284930
[TBL] [Abstract][Full Text] [Related]
6. A model of anticholinergic activity of atypical antipsychotic medications.
Chew ML; Mulsant BH; Pollock BG; Lehman ME; Greenspan A; Kirshner MA; Bies RR; Kapur S; Gharabawi G
Schizophr Res; 2006 Dec; 88(1-3):63-72. PubMed ID: 16928430
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of aripiprazole on D(2), 5-HT(2), and 5-HT(1A) receptor occupancy in patients with schizophrenia: a triple tracer PET study.
Mamo D; Graff A; Mizrahi R; Shammi CM; Romeyer F; Kapur S
Am J Psychiatry; 2007 Sep; 164(9):1411-7. PubMed ID: 17728427
[TBL] [Abstract][Full Text] [Related]
8. Targeting cognition in schizophrenia research: from etiology to treatment.
Goldberg TE; Gomar JJ
Am J Psychiatry; 2009 Jun; 166(6):631-4. PubMed ID: 19487396
[No Abstract] [Full Text] [Related]
9. Adjunctive antipsychotics for major depression.
Med Lett Drugs Ther; 2011 Sep; 53(1373):74-5. PubMed ID: 21921872
[No Abstract] [Full Text] [Related]
10. Treatment of psychosis: 30 years of progress.
De Oliveira IR; Juruena MF
J Clin Pharm Ther; 2006 Dec; 31(6):523-34. PubMed ID: 17176358
[TBL] [Abstract][Full Text] [Related]
11. Long-term metabolic effects of aripiprazole, ziprasidone and quetiapine: a pragmatic clinical trial in drug-naïve patients with a first-episode of non-affective psychosis.
Vázquez-Bourgon J; Pérez-Iglesias R; Ortiz-García de la Foz V; Suárez Pinilla P; Díaz Martínez Á; Crespo-Facorro B
Psychopharmacology (Berl); 2018 Jan; 235(1):245-255. PubMed ID: 29075885
[TBL] [Abstract][Full Text] [Related]
12. Dopamine system stabilizers, aripiprazole, and the next generation of antipsychotics, part 1, "Goldilocks" actions at dopamine receptors.
Stahl SM
J Clin Psychiatry; 2001 Nov; 62(11):841-2. PubMed ID: 11775041
[TBL] [Abstract][Full Text] [Related]
13. Atypical antipsychotics: matching receptor profile to individual patient's clinical profile.
Shayegan DK; Stahl SM
CNS Spectr; 2004 Oct; 9(10 Suppl 11):6-14. PubMed ID: 15475871
[TBL] [Abstract][Full Text] [Related]
14. Tardive dyskinesia in a patient treated with quetiapine.
Rizos E; Douzenis A; Gournellis R; Christodoulou C; Lykouras LP
World J Biol Psychiatry; 2009; 10(1):54-7. PubMed ID: 19673087
[TBL] [Abstract][Full Text] [Related]
15. Real-life switching strategies with second-generation antipsychotics.
Correll CU
J Clin Psychiatry; 2006 Jan; 67(1):160-1. PubMed ID: 16426102
[No Abstract] [Full Text] [Related]
16. The use of atypical antipsychotics after traumatic brain injury.
Elovic EP; Jasey NN; Eisenberg ME
J Head Trauma Rehabil; 2008; 23(2):132-5. PubMed ID: 18362767
[No Abstract] [Full Text] [Related]
17. Normalization of prolactin with aripiprazole in a patient with psychotic depression and a comorbid pituitary microadenoma.
Steinhagen CK
Psychosomatics; 2007; 48(4):350-1. PubMed ID: 17600173
[No Abstract] [Full Text] [Related]
18. An evaluation of inpatient treatment continuation and hospital readmission rates in patients with bipolar disorder treated with aripiprazole or quetiapine.
Kreys TJ; Fabian TJ; Saul MI; Haskett R; Coley KC
J Psychiatr Pract; 2013 Jul; 19(4):288-95. PubMed ID: 23852103
[TBL] [Abstract][Full Text] [Related]
19. Aripiprazole. Abilitat, OPC 14597.
Drugs R D; 2002; 3(1):25-7. PubMed ID: 11881525
[No Abstract] [Full Text] [Related]
20. Aripiprazole add-on treatment in a patient with schizoaffective disorder: neurocognitive outcomes.
Pfaffenberger N; Hoertnagl C; Fleischhacker WW; Hofer A
Pharmacopsychiatry; 2010 Aug; 43(6):234-5. PubMed ID: 20503152
[No Abstract] [Full Text] [Related]
[Next] [New Search]
